Yuhan's lazertinib royalties are expected to top 40 billion won on J&J sales up 62.3%
Yuhan is expected to collect over 40 billion won in lazertinib royalties this year after J&J's combined Q3 sales rose 62.3% to $320 million. Shinhan Securities projects 507 billion won a year by 2040, with 40% going to Oscotec, the original developer.
Reality
- Evidence40
- Adoption55
- Hype gap+30
- Incentives
- Not scored
- Confidence45
Hyundai Motor holds seventh place on the KOSPI by 7 trillion won after a 58% fall from June
Hyundai Motor's market value has fallen about 89.8 trillion won since June 1 as the share price lost 58.2%, en.sedaily.com reported. Seventh place on the KOSPI now rests on a lead of about 7.4 trillion won over KB Financial.
Reality
- Evidence70
- Adoption
- Not scored
- Hype gap
- Not scored
- Incentives
- Not scored
- Confidence65
Hong Kong buys 6.45 trillion won of Korean stocks through August while US and UK investors sell
Hong Kong was the second-largest foreign net buyer of Korean stocks through August at 6.45 trillion won, per FSS estimates. Hana Securities' omnibus accounts are one route into that total, and the report does not size their share.
Reality
- Evidence58
- Adoption
- Not scored
- Hype gap+12
- Incentives62
- Confidence52
Back-end chip suppliers lift the KOSDAQ to its first close above 900 since July
South Korea's KOSDAQ closed at 919.92, its first finish above 900 since July, as seven back-end chip suppliers averaged 54.86% gains since Sept. 1. The gains price in more AI spending by the big chipmakers, so the index still depends on Samsung and SK hynix budgets while their shares lag.
Reality
- Evidence62
- Adoption
- Not scored
- Hype gap+15
- Incentives
- Not scored
- Confidence55
Korea's licensed crypto exchanges lost 78% of operating income and a third of their combined market capitalization in H1 2026, a regulator survey shows. Bitcoin fell by the same third over the half, so the case for an exodus to offshore leverage has to rest on won deposits and turnover, figures that fit a move into Korean stocks just as well.
Reality
- Evidence62
- Adoption40
- Hype gap+35
- Incentives
- Not scored
- Confidence60
Institutions put 59% of their pre-Chuseok KOSPI buying into Samsung Electronics
Institutions net-bought 4.71 trillion won of KOSPI shares in the six sessions before Chuseok, 59% of it in Samsung Electronics. Retail and foreign holders sold into the 6.85% rise, so Samsung's preliminary results now test whether a bet that narrow holds the index above 7,000.
Reality
- Evidence62
- Adoption
- Not scored
- Hype gap+10
- Incentives
- Not scored
- Confidence60
Shinhan Asset Management works with three of the six blockchains courting Korean finance
At least six overseas blockchains signed payment and tokenization deals with Korean banks, brokerages and asset managers in the 93 days to Sept. 23. Many are still memorandums or pilots, and Shinhan Asset Management alone works with three of the networks, so Korean buyers are keeping their options open.
Reality
- Evidence45
- Adoption25
- Hype gap+15
- Incentives50
- Confidence40
Shinhan cuts five Korean brokerage targets after turnover fell 59% from June to September
Shinhan Securities now expects Mirae Asset Securities to earn 16.1 billion won in the third quarter against a 181.5 billion won consensus, and it has taken the stock's price target down 26%, to 37,000 won.
Reality
- Evidence54
- Adoption71
- Hype gap+9
- Incentives67
- Confidence57
Korea moves to codify margin ban for under-19s as brokerages roll out restrictions
Financial authorities are negotiating a formal bar on margin trading by investors under 19, after KB, Samsung and Shinhan each stopped it on their own schedules. Credit loans to buy shares rose 713 billion won in the week investor deposits fell 10.2 trillion.
Reality
- Evidence45
- Adoption55
- Hype gap+25
- Incentives55
- Confidence50
Korean savers pulled 18.95 trillion won out of money market funds in five days
The three-year treasury yield closed at 4.014% and WTI at $102.48, the KOSPI gave up the 7,000 level, and the money leaving Korea's safest funds landed in brokerage accounts with margin debt already at 32.36 trillion won.
Reality
- Evidence44
- Adoption61
- Hype gap+19
- Incentives46
- Confidence41
OpenAI prices its first Critical-rated model at 2.5 times the last one
Astra costs $10 per million input tokens and $50 per million output, both up the same 2.5 times, so the only way to hold spend flat is 60 percent fewer tokens. The capability being priced is the one rated Critical.
Reality
- Evidence22
- Adoption28
- Hype gap+45
- Incentives68
- Confidence34
DL E&C sustains housing margins above 20%, targets 2 trillion won in data centre orders
Operating profit rose 53% to 316.8 billion won while revenue shrank, so the entire gain is margin. The 1.2 trillion won of net cash it leaves behind is what pays for the plant and data centre work DL E&C has not yet won.
Reality
- Evidence62
- Adoption54
- Hype gap+24
- Incentives78
- Confidence58
Falling Saudi crude prices among several factors driving Korea's refiners rally
Korean refiners have run hard past the index this month, but the margin holding them up comes from Saudi Arabia repricing Asian crude by $11.50 a barrel and from product plants that have not come back yet.
Reality
- Evidence44
- Adoption52
- Hype gap+28
- Incentives60
- Confidence38
Twelve Korean brands rent shelf slots in Target's 600-store beauty reset
Target's new beauty floor hands Korean indie brands 12 of 90 slots, which is a lease on a planogram rather than a moat, and the only numbers in the file are door counts and SKU counts, with no sell-through yet.
Reality
- Evidence42
- Adoption58
- Hype gap+32
- Incentives66
- Confidence45
An mRNA vaccine cleared Phase 3 on Keytruda, and the read-through lands on Alteogen
Moderna and MSD's V940 hit both endpoints in adjuvant melanoma. The commercial consequence sits with Keytruda SC, whose conversion rate reached 10.6% in July.
Reality
- Evidence52
- Adoption44
- Hype gap+24
- Incentives72
- Confidence45
Korea's toxin and skin-booster export trade is now consensus, and the targets say so
Hugel and PharmaResearch posted record numbers on exports, and brokerages marked up targets within days. The upside now has to come from execution, not re-rating.
Reality
- Evidence58
- Adoption72
- Hype gap+16
- Incentives68
- Confidence57
Amgen drops AMG 513 for MariTide, and the obesity field narrows to a Phase 3 shortlist
The runners-up behind Lilly and Novo are consolidating around a few late-stage assets. Readouts starting next year, not messaging, will decide who takes share.
Reality
- Evidence32
- Adoption24
- Hype gap+22
- Incentives66
- Confidence36
Korean chip large-caps take the lead back, and the KOSDAQ's August looks borrowed
Foreigners swung from heavy net sellers to heavy net buyers of KOSPI shares in a single week as Samsung and SK hynix rebounded. The small-cap record run was a flow event.
Reality
- Evidence62
- Adoption
- Not scored
- Hype gap+14
- Incentives42
- Confidence55
A Yuanta broker out-earned his own CEO 24-fold in six months
Korean brokerages have tied retail pay so tightly to individual sales results that a trading boom now pays front-line contract staff many times what the people running the firms take home.
Reality
- Evidence48
- Adoption
- Not scored
- Hype gap+10
- Incentives30
- Confidence55
Shinhan Securities' 19.7% ROE rests on fee lines that have not met a drawdown
Product fee income rose 158% and IB revenue 248% in the first half. Both were earned in a rising market, and neither has been tested in a falling one.
Reality
- Evidence32
- Adoption46
- Hype gap+28
- Incentives78
- Confidence38